Gilead Sciences (GILD) PT Lowered to $89 at Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Gilead Sciences (GILD) PT Lowered to $90 at RBC Capital
May 2, 2018 8:26 AM EDTRBC Capital lowered its price target on Gilead Sciences (NASDAQ: GILD) to $90.00 (from $94.00) while maintaining an Outperform rating following a disappointing quarter.
... More
Gilead Sciences (GILD) PT Lowered to $79 at Baird
May 2, 2018 7:51 AM EDTBaird lowered its price target on Gilead Sciences (NASDAQ: GILD) to $79.00 (from $87.00) while maintaining an Outperform rating on weaker than expected 1Q.
Analyst Brian Skorney commented, "While investors had projected 2018 as a trough earnings year for the company, worse than expected sales... More
Gilead Sciences (GILD) PT Lowered to $81 at Morgan Stanley
May 2, 2018 7:45 AM EDTMorgan Stanley lowered its price target on Gilead Sciences (NASDAQ: GILD) to $81.00 (from $85.00) while maintaining a Equalweight rating following the company's 1Q earnings report.
1Q18 EPS missed by $0.17. The miss was driven by lower than expected total revenues ($5.1B vs. $5.4B... More
Gilead Sciences (GILD) PT Lowered to $85 at Cowen
May 2, 2018 6:31 AM EDTCowen lowered its price target on Gilead Sciences (NASDAQ: GILD) to $85.00 (from $90.00) while maintaining a Outperform rating.
... MoreGilead Sciences (GILD) PT Lowered to $72 at Leerink Partners
May 2, 2018 6:23 AM EDTLeerink Partners lowered its price target on Gilead Sciences (NASDAQ: GILD) to $72.00 (from $80.00) while maintaining a Market Perform rating.
... MoreGilead Sciences (GILD) PT Lowered to $90 at Barclays
May 2, 2018 3:54 AM EDTBarclays lowered its price target on Gilead Sciences (NASDAQ: GILD) to $90.00 (from $95.00) while maintaining a Overweight rating.
... More